ArticleTreat-to-Target Outcomes With Tapinarof Cream 1% in Phase 3 Trials for Plaque PsoriasisAuthor:Raj Chovatiya, MD, PhDPublish date: October 4, 2024 The National Psoriasis Foundation (NPF) treatment targets aim to achieve 1% or lower body surface area (BSA) affected...Read More
